Medpace Holdings, Inc. Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP

Clasificación en acciones #1197
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Precio por acción
$663.67
Capitalización bursátil
$18.52B
Cambio (1 día)
0.18%
Cambio (1 año)
21.39%
País
US
Comercio Medpace Holdings, Inc. (MEDP)

Categoría

Healthcare
Historial del precio de la acción de Medpace Holdings, Inc. (MEDP)
Precio más alto de cierre: $619.29 el 2026-10-01

Precio más bajo de cierre: $28.30 el 2016-08-01
Historial del precio de la acción de Medpace Holdings, Inc. desde 2016 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -4.61%
2025 64.84%
2024 15.73%
2023 41.41%
2022 -2.02%
2021 53.55%
2020 71.69%
2019 48.38%
2018 52.53%
2017 0.13%
2016 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$676.64 19.29%
US
$229.46 5.21%
US
$390.84 107.87%
US
$21.16 49.45%
CN
$172.39 18.18%
US